GLP-1 Inhibitors

About this episode

This episode discusses GLP-1 inhibitors and their impact on the pharmaceutical industry, focusing on key players and market dynamics.

GLP-1 drugs have become one of the most important developments in the pharmaceutical industry. With products like Ozempic, Wegovy, and Mounjaro in high demand, competition between drug makers is growing quickly. In this episode of Down to Business English, Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today’s weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. Their discussion also looks at a major recent development: Pfizer’s acquisition of biopharma startup Metsera, and why this deal could significantly change the market. Skip and Dez’s conversation gives listeners a clear and practical introduction to competition and strategy in the pharmaceutical industry — while helping you improve your Business English. In this episode, you will learn: What GLP-1 drugs are and what they are used for. The main differences between Ozempic, Wegovy, Mounjaro, and Zepbound. Why Eli Lilly is gaining market share, especially in North America. How Pfizer’s acquisition could affect future weight-loss treatments. Do you like what you hear? Become a D2B Member today for to access…

People in this episode

Hosts: Skip Montreux, Dez Morgan

Topics covered

• GLP-1 inhibitors
• pharmaceutical industry
• weight-loss drugs
• market competition
• business strategy
• Eli Lilly market share
• Pfizer acquisition

Keywords

• GLP-1 drugs
• Ozempic
• Wegovy
• Mounjaro
• Eli Lilly
• Pfizer acquisition
• weight-loss boom
• pharmaceutical competition

Mentioned in this episode

Organizations: Novo Nordisk, Eli Lilly, Pfizer, Metsera

Products: Ozempic, Wegovy, Mounjaro, Zepbound

More episodes of Down to Business English

• Guyana’s Oil Boom · May 28, 2026 · 22 min
• Sneakernomics Revisited · April 25, 2026 · 26 min
• The Great Kiwi Exodus · April 8, 2026 · 19 min
• Anthropic v. The United States · March 27, 2026 · 21 min
• Hallyu and the K-Beauty Industry · March 14, 2026 · 22 min
• SCOTUS Strikes Down Trump’s Trade Tariffs · February 28, 2026 · 17 min